Jean Michel Halfon - 04 Aug 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Reporting relationship: Director
Issuer ticker: TEVA
Reported as of: 04 Aug 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Aug 2022, 07:18:22 UTC
Prior SEC filing: 16 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Dov Bergwerk as attorney-in-fact for Jean-Michel Halfon

Key filing fact

Jean Michel Halfon filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 08 Aug 2022.

Key facts

This page summarizes Jean Michel Halfon's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Aug 2022, 07:18.

Change

Previous filing in this sequence was filed on 16 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TEVA transaction Derivative

Restricted Share Units

Award

Transaction value: $0
Shares: +15,810
Change %
Price: $0.000000
Shares after: 15,810
Date: 04 Aug 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 15,810
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

Footnote F2

Restricted share units were granted on August 4, 2022 and vest on August 4, 2023.

Footnote F3

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.